Login / Signup
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer.
Dun-Chang Mo
Tao Ren
Published in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Keyphrases
</>
drug delivery
cancer therapy
locally advanced
squamous cell carcinoma
recombinant human
rectal cancer